Cara Therapeutics announced the appointment of Helen Boudreau to its Board of Directors. Boudreau has more than 30 years of operating experience in a variety of industries, including the biotechnology and pharmaceutical sectors, in addition to serving as a director on numerous public boards. Prior to her retirement, Ms. Boudreau served as the Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CARA:
- Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
- Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
- Full value of Cara Therapeutics shares ‘far above’ present levels, says Stifel
- CMS proposal should ‘help unlock’ Cara Therapeutics shares, says Jefferies
- S&P DJI announces changes to S&P 600 at open on 6/20